National Health and Medical Research Council (NHMRC) National Institute for Dementia Research
The new Dementia Institute is up and running
The NHMRC National Institute for Dementia Research (The Dementia Institute) is a key element of the $200 million initiative to boost dementia research.
As part of the $200 million commitment to dementia research, the Australian Government has already announced $35.6 million for NHMRC Dementia Research Team Grants, and $43.7 million in funding for the NHMRC-ARC Dementia Research Development Fellowships, and $2.6 million to fund two major Australian dementia studies which will be part the European Union Joint Programme for Neurodegenerative Disease.
The new Dementia Institute will target, coordinate and translate the strategic expansion of dementia research in Australia. The Institute will collaborate with Australia’s best researchers while also drawing on the expertise of consumers, health professionals, industry and policy makers to translate evidence into policy and practice. Through collaboration, including with international partnerships, achieving a five year delay in the onset of dementia by 2025 is the international priority set by the World Dementia Council to which the Dementia Institute will make a significant contribution.
Information about the Dementia Institute Secretariat can be found in the October edition of the Dementia Institute’s newsletter - Dementia Dispatch.
The Secretariat consists of:
- Professor John McCallum, Director
- Dr Christopher Pettigrew, Senior Research Policy Officer
- Kayla Borman, Executive Assistant & Administration Support Officer
The Dementia Institute is also developing its own website which will be launched soon. In the meantime you can follow the Dementia Institute on Twitter at https://twitter.com/NNIDResearch.
Read the Institute’s most recent media releases on the Dementia Australia website.
- 19 October 2015: 76 of Australia’s Best New Research Fellows Receive Funding to Fight Dementia
- 9 November 2015: Two major Australian dementia studies receive $2.6m to partner with one of the world’s biggest neurodegenerative research programmes